-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Aflibercept ophthalmic solution: drug development and clinical uses
Michael W Stewart
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
The potential role of new targeted therapies in the treatment of advanced non-small-cell lung cancer
Francesca Casaluce, Assunta Sgambato, Paolo Maione, Antonio Rossi, Carmine Ferrara, Alba Napolitano, Giovanni Palazzolo, Fortunato Ciardiello, Cesare Gridelli
Review: Clinical Trail Outcomes: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Challenges of developing new drugs for childhood cancers
Frank M Balis, Elizabeth Fox
Clinical Trail Perspective: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Developing an international network for clinical research: the Community-Acquired Pneumonia Organization experience
Paula Peyrani, Timothy Wiemken, Forest Arnold,Julio Ramirez
Clinical Trail Outcomes: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation
-
Pazopanib in the treatment of renal cell carcinoma
C Lance Cowey, Thomas E Hutson, Robert Figlin
Review Article: Clinical Investigation